www.ijpsonline.com [4- (Shimadzu) and operating software Shimadzu class LC-10 (5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonamide is data station was used. The chromatography column used the newest addition to the group of non-steroidal was reverse phase Luna C 18 column (250 mm×4.6 mm i.d, antiinflammatory drugs (NSAIDs) known as selective coxparticle size 5 µ). 2 inhibitor. This drug has been recently approved by the USFDA for treatment of rheumatoid arthritis, osteoarthritis A mixture of acetonitrile and 10 mM phosphate buffer and pain [6] [7] [8] [9] [10] [11] [12] . TZ and VAL are not official in any (adjusted to pH 3.5 using orthophosphoric acid) in the pharmacopoeia. A tablet formulation containing 2 mg of ratio 50:50 v/v was used as mobile phase and was filtered TZ and 20 mg of VAL is available in market (Zulu-V, before use through 0.45 µ Millipore membrane filter. The Altoz Life Science). A survey of literature revealed that flow rate of mobile phase was maintained at 0.5 ml/min. few chromatographic and Spectrophotometric methods are Detection was carried out at 227 nm at the room reported for determination of TZ and VAL individually [8] [9] [10] [11] .
RP RP RP RP RP-HPLC Estimation of T -HPLC Estimation of T -HPLC Estimation of T -HPLC Estimation of T -HPLC Estimation of Tizanidine
temperature. However there is no HPLC method reported for simultaneous determination of TZ and VAL from combine Standard stock solution of VAL, TZ and etoricoxib (1 dosage form. The present work describes a simple, mg/ml) was prepared in mobile phase. A gradient high performance liquid chromatography (Shimadzu HPLC class LC-10 series) with two LC-10 AT *For correspondence E-mail: gstalele@rediffmail.com prepared containing 0.8 µg/ml of TZ, 8 µg/ml of VAL and 10 µg/ml of etoricoxib. Twenty tablets, each containing 2 mg of TZ and 20 mg of VAL were weighed and finely powdered. A quantity of powder equivalent to 2 mg of TZ and 20 mg of VAL was weighed and transferred to 100 ml volumetric flask containing 50 ml mobile phase. The mixture was sonicated for 10 min. The volume was made up to 100 ml with mobile phase. Further dilutions were made to get a concentration of 0.8 µg/ml of TZ, 8 µg/ml of VAL and 10 µg/ml of etoricoxib as internal standard (theoretical value). The contents were vortexed and filtered through 0.22 µ membrane filter. Twenty microliters of the test and standard solutions were www.ijpsonline.com injected separately and chromatograms were recorded upto 20 min.
The present investigation was aimed at developing a simple, precise and accurate HPLC method to estimate TZ and VAL in tablet using the widely used RP-HPLC C 18 column (Luna). The mobile phase was optimized with acetonitrile and 10 mM Potassium dihydrogen ortho phosphate buffer (pH 3.5) in the proportion of 50:50 v/v. With the above mentioned composition of mobile phase a good resolution between TZ and VAL was achieved. UV detection was carried out at 227 nm as both the drugs showed good absorbance at this wavelength.
The retention time of TZ and VAL was found to be 4.43 and 16.60 min, respectively. A typical chromatogram of the test solution is shown in the fig. 1 . The capacity factor of VAL was found to be 2.72. The peak shape of both drugs were symmetrical and asymmetric factor was lesser than 2.0. The response factor (peak area ratio of standard peak area and internal standard peak area) of the standard and test solution was calculated. The proposed method was validated as per ICH guidelines. Each of the samples was injected 6 times and the retention time was observed in all the cases. Precision of proposed method (RSD) was found to be 0.65% for TZ and 0.08% for VAL. The low RSD value indicated that proposed method had good precision. Linearity experiments were performed thrice for the both the compounds and the response was found to be linear in the range of 0.4-2.0 µg/ml for TZ and 4-20 µg/ml for VAL. Linearity of TZ and VAL was plotted by a graph of response factor versus concentration. The correlation coefficient (r) values (n=3) for TZ and VAL were 0.9993 and 0.9994, respectively. Accuracy of the method was calculated by recovery studies (n=3) at three levels. Amount of drug recovered at each level (n=3) was calculated. Percent recovery study at each level was calculated. Table 1 shows the data from the recovery
Parameters Tizanidine
Tailing factor 1.57 study for TZ and VAL. The average recovery of TZ and VAL were 100.5 and 100.3%, respectively. The sample recovery in the formulation was in good agreement with the label claim. High percentage recovery showed that the method was free from interferences of excipients used in the formulations. The system suitability parameters of valdecoxib and tizanidine are given in Table 2 . Assay of the combination in tablet dosage form was found to be 98.5% of TZ and 98.4% of VAL. The results of study indicate that proposed method is simple, precise, highly accurate and specific.
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